ASTELLAS CONCIERGE SERVICES
DEAD

Serial Number

85564679

Owner

ASTELLAS PHARMA INC.

Attorney

Kaushal R. Odedra

Filing Date

Mar 8, 2012

Add to watchlist:

No watchlists yet
View on USPTO

ASTELLAS CONCIERGE SERVICES Trademark

Serial Number: 85564679 • Registration: 4294737

ASTELLAS CONCIERGE SERVICES is a trademark filed by ASTELLAS PHARMA INC. on March 8, 2012. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

ASTELLAS PHARMA INC. (257 trademarks)

3-11 NIHONBASHI-HONCHO 2-CHOME, CHUO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

March 8, 2012

Registration Date

February 26, 2013

Published for Opposition

December 11, 2012

Cancellation Date

September 27, 2019

Goods & Services

Educational services, namely, providing training and instruction in the use of specialized drug administration techniques and conducting seminars in the medical field

Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer, namely, tumor suppressing agents; antibiotics, antifungals, anti-viral drugs; vaccines for the treatment of infectious diseases; diagnostic preparations for medical purposes for use in testing urine, fecal occult blood and other blood diseases, namely, anemia, leukemia, hemophilia; pharmaceuticals for human use, namely, anthelmintics; sanitary preparations, namely, germicides

Insurance agencies excluding life insurance agencies; providing information on Insurance matters; providing grants to patients and their families for improving their quality of life; providing grants to medical research organizations and business associations in support of scientific, medical and business meetings and workshops; providing grants to educational institutions and research organizations in support of educating the public about medical issues

Management of telephone call centers for others; operation of telephone call centers for others; administration of patient reimbursement programs in order to assist patients in obtaining reimbursements from insurers of health care costs

Providing health care services, namely, providing health care information to patients by means of a toll-free telephone number, medical evaluation services, namely, assessment program for patients receiving drug treatment services for the purpose of monitoring patient's compliance with drug procedures and providing medical advisory services related thereto

Research and consultation services in the field of biotechnology

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 27, 2019 C8..
REGISTERED-PRINCIPAL REGISTER
Feb 26, 2013 R.PR
PUBLISHED FOR OPPOSITION
Dec 11, 2012 PUBO
NOTICE OF PUBLICATION
Nov 21, 2012 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 5, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 1, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 27, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2012 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 17, 2012 ERSI
LETTER OF SUSPENSION MAILED
Jul 24, 2012 CNSL
SUSPENSION LETTER WRITTEN
Jul 24, 2012 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 23, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 23, 2012 CRFA
ASSIGNED TO LIE
Jul 12, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 2, 2012 TROA
NON-FINAL ACTION MAILED
Apr 12, 2012 CNRT
NON-FINAL ACTION WRITTEN
Apr 12, 2012 CNRT
ASSIGNED TO EXAMINER
Apr 11, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 15, 2012 NWOS
NEW APPLICATION ENTERED
Mar 12, 2012 NWAP